Local delivery of basic fibroblast growth factor increases both angiogenesis and engraftment of hepatocytes in tissue-engineered polymer devices

Hanmin Lee, Robert A. Cusick, Fiona Browne, Tae Ho Kim, Peter X. Ma, Hirofumi Utsunomiya, Robert Langer, Joseph P. Vacanti

Research output: Contribution to journalArticlepeer-review

113 Scopus citations


Background. We investigated heterotopic hepatocyte transplantation on biodegradable polymers as a potential treatment for end-stage liver disease. The primary problem has been insufficient engraftment of transplanted cells partly because of insufficient vascularization. Increasing vascularization through locally delivered angiogenic factors may increase angiogenesis and hepatocyte engraftment. Methods. We studied the effect of local delivery of basic fibroblast growth factor (bFGF) on angiogenesis and hepatocyte engraftment within tissue-engineered liver constructs. Poly-L-lactic acid discs were fabricated and coated with either a mixture of saline, sucralfate, and Hydron (control group) or bFGF, sucralfate, and Hydron (bFGF group). bFGF release from polymers in vitro was tested using an ELISA. Hepatocytes were isolated from Lewis rats, seeded on control (n=9) or bFGF (n=11) polymers, and implanted into the small bowel mesentery of syngeneic animals. Specimens were harvested after 2 weeks and analyzed for hepatocyte engraftment. Microvascular density was compared between control (n=6) and bFGF groups (n=5). Results. Three hundred twenty-three thousandths of a microgram of bFGF were incorporated per polymer. Greater than 99% of the bFGF was released into solution by 72 hr in vitro. Two weeks after implantation, microvascular density, as measured by capillaries per high-powered field (c/hpf), was significantly greater in the bFGF group (43.8 c/hpf), compared with the control group (30.5 c/hpf, P<0.005). Specimens from the bFGF group (mean engraftment, 61,355 μm2) showed a 2.5-fold increase in hepatocyte engraftment as comFetal Treatment Center, University of California, San Francisco, 513 Parnassus, Suite HSW 1601, San Francisco CA 94143-0570 pared with control (24,197 μm2; P<0.002). Conclusions. The angiogenic growth factor bFGF can be incorporated into degradable polymers used as delivery devices for hepatocyte transplantation. Implantation of these devices increases angiogenesis into the device and increases hepatocyte engraftment.

Original languageEnglish (US)
Pages (from-to)1589-1593
Number of pages5
Issue number10
StatePublished - May 27 2002
Externally publishedYes

ASJC Scopus subject areas

  • Transplantation


Dive into the research topics of 'Local delivery of basic fibroblast growth factor increases both angiogenesis and engraftment of hepatocytes in tissue-engineered polymer devices'. Together they form a unique fingerprint.

Cite this